are by definition not confined to a particular vascular territory. However, it is conceivable that during the development of the primary metabolic defect, not only are neurons and astrocytes involved but, secondarily, so too are local mediumand small-sized arteries, and veins. This would explain why parts of stroke-like lesions can appear as an ischemic lesion in certain stages of the stroke-like lesion. Affection of the arteries is supported by muscle biopsy findings showing SDH-hyper-reactive vessel walls and by primary macro-or microangiopathy in mitochondrial disorders 7 . Mitochondrial macroangiopathy may manifest as atherosclerosis, ectasia of arteries, aneurysm formation, dissection, or spontaneous rupture of arteries 7 . Mitochondrial microangiopathy may manifest as leukoencephalopathy, migraine-like headache, or retinal vasculopathy 7 .
Concerning treatment, it has to be mentioned that the ketogenic diet (low glycemic, high fat content) may be beneficial in individual MELAS patients 8 . The ketogenic diet may be particularly effective for seizures and SLEs 9 . The ketogenic diet increases the production of ketone bodies, a side effect of which may be metabolic acidosis, which again increases the propensity of seizures 10 . However, by modifying the diet by monitoring the protein intake and by maximizing consumption of alkaline mineral-rich, low carbohydrate green vegetables, metabolic acidosis can be spared 10 .
In summary, we propose to define MELAS upon the presence of a stroke-like lesion on MRI, upon ragged-red fibers, SDH-hyper-reactive muscular arteries, and normal COX staining on muscle biopsy, and lactic acidosis, to differentiate MELAS from myoclonic epilepsy with ragged red fibers syndrome and other mitochondrial syndromes. The pathogenicity and distribution of mutations associated with MELAS can be assessed reliably only if there is general agreement on what can be diagnosed clinically as MELAS and what is not MELAS.
